Skip to main content
Top
Published in: Drug Safety 11/2010

01-11-2010 | Original Research Article

Comparison of Three Methods (Consensual Expert Judgement), (Algorithmic and Probabilistic Approaches) of Causality Assessment of Adverse Drug Reactions

An Assessment Using Reports Made to a French Pharmacovigilance Centre

Authors: Hélène Théophile, Yannick Arimone, Ghada Miremont-Salamé, Nicholas Moore, Annie Fourrier-Réglat, Françoise Haramburu, Bernard Bégaud

Published in: Drug Safety | Issue 11/2010

Login to get access

Abstract

Background: Different methods have been proposed for assessing a possible causal link between a drug treatment and an adverse event in individual patients. They approximately belong to three main categories: expert judgement, operational algorithms and probabilistic approaches.
Objective: To compare, in a set of actual drug adverse event reports, three different methods for assessing drug causality, each belonging to one of the three main categories: expert judgement, the algorithm used by the French pharmacovigilance centres since 1985, and a novel method based on the logistic function.
Methods: Fifty drug-event pairs were randomly sampled from the database of the Bordeaux pharmacovigilance centre, France. To serve as the gold standard, the probability for drug causation, from 0 to 1, was first determined for each drug-event pair by a panel of senior experts until consensus was reached. Causality was then assessed by members of the Bordeaux pharmacovigilance centre by using the French algorithm and the logistic method. Results expressed as a probability with the logistic method and as a score from 0 to 4 with the French algorithm were then compared with consensual expert judgement, as were the sensitivity, specificity and positive and negative predictive values.
Results: Probabilities ranged from 0.08 to 0.99 (median 0.58; mean 0.60) for experts versus 0.18–0.88 (median 0.73; mean 0.67) for the logistic method. Consensual expert judgement was not discriminant (p = 0.50) in ten cases. For the algorithm, only three of five causality scores were found, doubtful scores being clearly predominant (74%) followed by possible (16%) and probable (10%) scores. Sensitivity and specificity were 0.96 and 0.42, respectively, for the logistic method versus 0.42 and 0.92 for the algorithm. Positive and negative predictive values were 0.78 and 0.83, respectively, for the logistic method versus 0.92 and 0.42 for the algorithm.
Conclusions: Agreement between the three approaches was poor, and only satisfactory for drug events judged as drug-induced by consensual expert judgement. The logistic method showed high sensitivity at the expense of poor specificity. Conversely, the algorithm had poor sensitivity but good specificity. The comparatively good sensitivity and positive predictive values of the logistic method suggest that it may be more useful in the routine or automated assessment of case reports of suspected but still unknown adverse drug reactions. With a substantial rate of false positives relative to true negatives (low specificity), the logistic method does not replace, but can be complemented by, critical clinical assessment of individual cases in evaluating drug-related risk.
Literature
1.
go back to reference Agbabiaka TB, Savovic J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf 2008; 31(1): 21–37PubMedCrossRef Agbabiaka TB, Savovic J, Ernst E. Methods for causality assessment of adverse drug reactions: a systematic review. Drug Saf 2008; 31(1): 21–37PubMedCrossRef
2.
go back to reference Meyboom RH, Hekster YA, Egberts AC, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374–89PubMedCrossRef Meyboom RH, Hekster YA, Egberts AC, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374–89PubMedCrossRef
3.
go back to reference Stephens MD. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987; 6: 1–35PubMed Stephens MD. The diagnosis of adverse medical events associated with drug treatment. Adverse Drug React Acute Poisoning Rev 1987; 6: 1–35PubMed
4.
go back to reference Blanc S, Leuenberger P, Berger JP, et al. Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979; 25: 493–8PubMed Blanc S, Leuenberger P, Berger JP, et al. Judgments of trained observers on adverse drug reactions. Clin Pharmacol Ther 1979; 25: 493–8PubMed
5.
go back to reference Karch FE, Smith CL, Kerzner B, et al. Adverse drug reactions: a matter of opinion. Clin Pharmacol Ther 1976; 19: 489–92PubMed Karch FE, Smith CL, Kerzner B, et al. Adverse drug reactions: a matter of opinion. Clin Pharmacol Ther 1976; 19: 489–92PubMed
6.
go back to reference Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977; 11: 75–8PubMedCrossRef Koch-Weser J, Sellers EM, Zacest R. The ambiguity of adverse drug reactions. Eur J Clin Pharmacol 1977; 11: 75–8PubMedCrossRef
7.
go back to reference Kramer MS. Difficulties in assessing the adverse effects of drugs. Br J Clin Pharmacol 1981; 11 Suppl. 1: 105–10S Kramer MS. Difficulties in assessing the adverse effects of drugs. Br J Clin Pharmacol 1981; 11 Suppl. 1: 105–10S
8.
go back to reference Rowe G, Wright G. The Delphi technique as a forecasting tool: issues and analysis. Int J Forecast 1999; 15: 353–75CrossRef Rowe G, Wright G. The Delphi technique as a forecasting tool: issues and analysis. Int J Forecast 1999; 15: 353–75CrossRef
9.
go back to reference Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clin Pharmacol Ther 1995; 58: 692–8PubMedCrossRef Lanctot KL, Naranjo CA. Comparison of the Bayesian approach and a simple algorithm for assessment of adverse drug events. Clin Pharmacol Ther 1995; 58: 692–8PubMedCrossRef
10.
go back to reference Auriche M. Bayesian approach to the imputability of undesirable phenomena to drugs. Therapie 1985; 40: 301–6PubMed Auriche M. Bayesian approach to the imputability of undesirable phenomena to drugs. Therapie 1985; 40: 301–6PubMed
11.
go back to reference Kramer MS. Imputabilité des effets indésirables: individu (analyse du cas) versus groupe (épidémiologie). 3es entretiens. Lyon: Jacques Cartier, 1989: 31–44 Kramer MS. Imputabilité des effets indésirables: individu (analyse du cas) versus groupe (épidémiologie). 3es entretiens. Lyon: Jacques Cartier, 1989: 31–44
12.
go back to reference Péré JC, Godin MH, Bégaud B, et al. Sensitivity and specificity of imputability criteria: study and comparison of these efficacity indices for 7 methods. Therapie 1985; 40: 307–12PubMed Péré JC, Godin MH, Bégaud B, et al. Sensitivity and specificity of imputability criteria: study and comparison of these efficacity indices for 7 methods. Therapie 1985; 40: 307–12PubMed
13.
go back to reference Arimone Y, Bégaud B, Miremont-Salamé G, et al. A new method for assessing drug causation provided agreement with experts’ judgment. J Clin Epidemiol 2006; 59: 308–14PubMedCrossRef Arimone Y, Bégaud B, Miremont-Salamé G, et al. A new method for assessing drug causation provided agreement with experts’ judgment. J Clin Epidemiol 2006; 59: 308–14PubMedCrossRef
14.
go back to reference Thiessard F, Roux E, Miremont-Salamé G, et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986–2001). Drug Saf 2005; 28: 731–40PubMedCrossRef Thiessard F, Roux E, Miremont-Salamé G, et al. Trends in spontaneous adverse drug reaction reports to the French pharmacovigilance system (1986–2001). Drug Saf 2005; 28: 731–40PubMedCrossRef
15.
go back to reference Bégaud B, Evreux JC, Jouglard J, et al. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France. Therapie 1985; 40: 111–8PubMed Bégaud B, Evreux JC, Jouglard J, et al. Imputation of the unexpected or toxic effects of drugs: actualization of the method used in France. Therapie 1985; 40: 111–8PubMed
16.
go back to reference Meyboom RH, Hekster YA, Egberts AC, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374–89PubMedCrossRef Meyboom RH, Hekster YA, Egberts AC, et al. Causal or casual? The role of causality assessment in pharmacovigilance. Drug Saf 1997; 17: 374–89PubMedCrossRef
17.
18.
go back to reference Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–54PubMed Karch FE, Lasagna L. Toward the operational identification of adverse drug reactions. Clin Pharmacol Ther 1977; 21: 247–54PubMed
19.
go back to reference Macedo AF, Marques FB, Ribeiro CF. Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? Drug Saf 2006; 29: 697–702PubMedCrossRef Macedo AF, Marques FB, Ribeiro CF. Can decisional algorithms replace global introspection in the individual causality assessment of spontaneously reported ADRs? Drug Saf 2006; 29: 697–702PubMedCrossRef
20.
go back to reference Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 1981; 30: 239–45PubMedCrossRef
21.
go back to reference Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 2003; 28: 137–43PubMedCrossRef Macedo AF, Marques FB, Ribeiro CF, et al. Causality assessment of adverse drug reactions: comparison of the results obtained from published decisional algorithms and from the evaluations of an expert panel, according to different levels of imputability. J Clin Pharm Ther 2003; 28: 137–43PubMedCrossRef
22.
go back to reference Miremont G, Haramburu F, Bégaud B, et al. Adverse drug reactions: physicians’ opinions versus a causality assessment method. Eur J Clin Pharmacol 1994; 46: 285–9PubMedCrossRef Miremont G, Haramburu F, Bégaud B, et al. Adverse drug reactions: physicians’ opinions versus a causality assessment method. Eur J Clin Pharmacol 1994; 46: 285–9PubMedCrossRef
23.
go back to reference Benahmed S, Picot MC, Hillaire-Buys D, et al. Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions. Eur J Clin Pharmacol 2005; 61(7): 537–41PubMedCrossRef Benahmed S, Picot MC, Hillaire-Buys D, et al. Comparison of pharmacovigilance algorithms in drug hypersensitivity reactions. Eur J Clin Pharmacol 2005; 61(7): 537–41PubMedCrossRef
24.
go back to reference Eiden C, Peyrière H. Comparaison de deux méthodes d’imputabilité des effets indésirables du voriconazole notifiés dans la base nationale de pharmacovigilance: Begaud versus Naranjo. Pharmacien Hospitalier 2009; 44(4): 186–9CrossRef Eiden C, Peyrière H. Comparaison de deux méthodes d’imputabilité des effets indésirables du voriconazole notifiés dans la base nationale de pharmacovigilance: Begaud versus Naranjo. Pharmacien Hospitalier 2009; 44(4): 186–9CrossRef
25.
go back to reference Koh Y, Yap CW, Li SC. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. Int J Med Inform 2008; 77(6): 421–30PubMedCrossRef Koh Y, Yap CW, Li SC. A quantitative approach of using genetic algorithm in designing a probability scoring system of an adverse drug reaction assessment system. Int J Med Inform 2008; 77(6): 421–30PubMedCrossRef
Metadata
Title
Comparison of Three Methods (Consensual Expert Judgement), (Algorithmic and Probabilistic Approaches) of Causality Assessment of Adverse Drug Reactions
An Assessment Using Reports Made to a French Pharmacovigilance Centre
Authors
Hélène Théophile
Yannick Arimone
Ghada Miremont-Salamé
Nicholas Moore
Annie Fourrier-Réglat
Françoise Haramburu
Bernard Bégaud
Publication date
01-11-2010
Publisher
Springer International Publishing
Published in
Drug Safety / Issue 11/2010
Print ISSN: 0114-5916
Electronic ISSN: 1179-1942
DOI
https://doi.org/10.2165/11537780-000000000-00000

Other articles of this Issue 11/2010

Drug Safety 11/2010 Go to the issue